fluoxetine has been researched along with Labhart-Willi Syndrome in 11 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report an aggravation in the food-related symptoms and a consequent weight gain in an adolescent with Prader-Willi syndrome, who was treated with fluvoxamine and fluoxetine." | 7.71 | Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine. ( Apter, A; Kohn, Y; Weizman, A, 2001) |
| "Hypogonadotropic hypogonadism is a major characteristic of patients with PWS, and it is speculated to be due to hypothalamic insufficiency." | 5.29 | Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. ( Clayton, AH; O'Donnell, T; Shaw, HA; Warnock, JK, 1995) |
| "We report an aggravation in the food-related symptoms and a consequent weight gain in an adolescent with Prader-Willi syndrome, who was treated with fluvoxamine and fluoxetine." | 3.71 | Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine. ( Apter, A; Kohn, Y; Weizman, A, 2001) |
| "Obesity is a major cause of increased morbidity and mortality among patients with PWS." | 2.44 | [Therapeutical approach of obesity in Prader-Willi Syndrome]. ( Almeida, MQ; Carvalho, DF; Cercato, C; Halpern, A; Mancini, MC, 2007) |
| "Hypogonadotropic hypogonadism is a major characteristic of patients with PWS, and it is speculated to be due to hypothalamic insufficiency." | 1.29 | Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. ( Clayton, AH; O'Donnell, T; Shaw, HA; Warnock, JK, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hergüner, S | 1 |
| Motavalli Mukaddes, N | 1 |
| Carvalho, DF | 1 |
| Cercato, C | 1 |
| Almeida, MQ | 1 |
| Mancini, MC | 1 |
| Halpern, A | 1 |
| Warnock, JK | 3 |
| Clayton, AH | 1 |
| Shaw, HA | 1 |
| O'Donnell, T | 1 |
| Hellings, JA | 1 |
| Benjamin, E | 1 |
| Buot-Smith, T | 1 |
| Jerome, L | 2 |
| Schepis, C | 1 |
| Failla, P | 1 |
| Siragusa, M | 1 |
| Palazzo, R | 1 |
| Romano, C | 1 |
| Kohn, Y | 1 |
| Weizman, A | 1 |
| Apter, A | 1 |
| Kestenbaum, T | 1 |
| Dech, B | 1 |
| Budow, L | 1 |
1 review available for fluoxetine and Labhart-Willi Syndrome
| Article | Year |
|---|---|
[Therapeutical approach of obesity in Prader-Willi Syndrome].
Topics: Adolescent; Anti-Obesity Agents; Bariatric Surgery; Child; Child, Preschool; Female; Fluoxetine; Fru | 2007 |
10 other studies available for fluoxetine and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Psychosis associated with fluoxetine in Prader-Willi syndrome.
Topics: Adolescent; Chromosome Deletion; Chromosomes, Human, Pair 15; Compulsive Behavior; Female; Fluoxetin | 2007 |
Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
Topics: Adult; Age of Onset; Female; Fluoxetine; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; | 1995 |
Self-injurious behavior and serotonin in Prader-Willi syndrome.
Topics: Adult; Female; Fluoxetine; Humans; Male; Prader-Willi Syndrome; Self-Injurious Behavior; Serotonin | 1994 |
Naltrexone and fluoxetine in Prader-Willi syndrome.
Topics: Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxe | 1993 |
Prader-Willi and bipolar illness.
Topics: Adult; Bipolar Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Prader-Will | 1993 |
Failure of fluoxetine to modify the skin-picking behaviour of Prader-Willi syndrome.
Topics: Adolescent; Adult; Compulsive Behavior; Female; Fluoxetine; Humans; Male; Prader-Willi Syndrome; Sel | 1998 |
Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
Topics: Adolescent; Feeding and Eating Disorders; Fluoxetine; Fluvoxamine; Humans; Male; Prader-Willi Syndro | 2001 |
Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
Topics: Adult; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Prader-Willi Syndrome; Self | 1992 |
Pharmacotherapy of eating and behavioral problems.
Topics: Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Male; Met | 1991 |
The use of fluoxetine in an adolescent with Prader-Willi syndrome.
Topics: Adolescent; Behavior Therapy; Feeding and Eating Disorders; Female; Fluoxetine; Hospitalization; Hum | 1991 |